Joint BAP NAPICU evidence based guidelines for the clinical management of acute disturbance (de-escalation and rapid tranquillisation)
In-Person Event
Jun 08, 2018
London, England, GB
OVERVIEW
Joint BAP NAPICU evidence based guidelines for the clinical management of acute disturbance is organized by British Association for Psychopharmacology (BAP), National Association of Psychiatric Intensive Care and Low Secure Units (NAPICU) and will be held on Jun 08, 2018 at Hallam Conference Centre, London, England, United Kingdom.
The British Association for Psychopharmacology (BAP) and the National Association of Psychiatric Intensive Care and Low Secure Units (NAPICU) have developed this new joint guideline which reviews the use of de-escalation methods and psychotropic medication for the clinical management of acute disturbance. Although the most recent NICE guidelines reviewed randomized controlled trial evidence for the use of intramuscular medication in rapid tranquillization, they placed relatively little emphasis on the use of oral or other formulations of medication in the stages before rapid tranquillization or indeed de-escalation techniques. Our guideline will focus on three key interventions: de-escalation, pharmacological interventions pre rapid tranquillization, and rapid tranquillization (intramuscular and intravenous).
This meeting introduces our new guideline and algorithm to guide treatment and comprises speakers from the group who have developed this document and who are experts in its clinical, research and policy implications. We will cover state-of-the-art and pragmatic updates, with key recommendations. The meeting will be an excellent educational opportunity and will provide an essential update for those with an interest in treating acute disturbance in acute adult psychiatric, psychiatric intensive care, forensic and general hospital settings.
Attendance at this meeting is suitable for up to 5 units of CPD approval, subject to verification by peer group as part of an individual member’s Personal Development Plan.
Additional details will be posted as soon as they are available.
The British Association for Psychopharmacology (BAP) and the National Association of Psychiatric Intensive Care and Low Secure Units (NAPICU) have developed this new joint guideline which reviews the use of de-escalation methods and psychotropic medication for the clinical management of acute disturbance. Although the most recent NICE guidelines reviewed randomized controlled trial evidence for the use of intramuscular medication in rapid tranquillization, they placed relatively little emphasis on the use of oral or other formulations of medication in the stages before rapid tranquillization or indeed de-escalation techniques. Our guideline will focus on three key interventions: de-escalation, pharmacological interventions pre rapid tranquillization, and rapid tranquillization (intramuscular and intravenous).
This meeting introduces our new guideline and algorithm to guide treatment and comprises speakers from the group who have developed this document and who are experts in its clinical, research and policy implications. We will cover state-of-the-art and pragmatic updates, with key recommendations. The meeting will be an excellent educational opportunity and will provide an essential update for those with an interest in treating acute disturbance in acute adult psychiatric, psychiatric intensive care, forensic and general hospital settings.
Attendance at this meeting is suitable for up to 5 units of CPD approval, subject to verification by peer group as part of an individual member’s Personal Development Plan.
Additional details will be posted as soon as they are available.
KEY DATES
08 Jun, 2018
Event Start Date
08 Jun, 2018
Event End Date
SPECIALITIES
PsychiatryTraumaSUGGESTED HOTELS
CONFERENCE VENUE
Hallam Conference CentreRELATED CONFERENCES & LIVE WEBINARS
Quick Links